Results 221 to 230 of about 72,279 (314)
Editorial Note: Extensive culturomics of 8 healthy samples enhances metagenomics efficiency. [PDF]
PLOS One Editors.
europepmc +1 more source
Differences in the Fecal Metabolome of Autoimmune Pancreatitis Patients
ABSTRACT Background Chronic pancreatitis is a risk factor for pancreatic cancer. Autoimmune pancreatitis is a unique form of chronic pancreatitis that is primarily characterized by its immune mediate etiology, clinically resembling pancreatic cancer, yet uniquely responsive to steroid treatment.
Vladyslav Dovhalyuk+5 more
wiley +1 more source
Strategies Used for the Discovery of New Microbial Metabolites with Antibiotic Activity. [PDF]
Dasí-Delgado P, Andreu C, Del Olmo ML.
europepmc +1 more source
Gut Microbiota as a Mediator Between Intestinal Fibrosis and Creeping Fat in Crohn's Disease
ABSTRACT Intestinal stricture remains one of the most challenging complications in Crohn's disease, and its underlying mechanisms are poorly understood. Accumulating evidence suggests that gut microbiota is significantly altered in stenotic intestines and may play a key role in the development of fibrogenesis in Crohn's disease.
Caiguang Liu+14 more
wiley +1 more source
Advancing molecular macrobenthos biodiversity monitoring: a comparison between Oxford Nanopore and Illumina based metabarcoding and metagenomics. [PDF]
Doorenspleet K+8 more
europepmc +1 more source
ABSTRACT Background and Aims The relationship between gut microbiota and biological treatment response in inflammatory bowel disease (IBD) remains incompletely understood. We sought to characterize microbial signatures associated with clinical remission and develop a prediction model for clinical remission. Methods We analyzed 16 S rRNA gene sequencing
Qingyang Zheng+10 more
wiley +1 more source